Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Use of Transexamic Acid in Hip Replacement
Phase 3
- Conditions
- BleedingTransfusion Related Complication
- Interventions
- Drug: Tranexamic Acid (IV)Drug: Tranexamic Acid (Topical)
- First Posted Date
- 2015-10-27
- Last Posted Date
- 2015-10-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT02587845
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Myocardial Flow Reserve in Severe AS Without Obstructive Coronary Artery Disease
Completed
- Conditions
- Severe Aortic StenosisChest Pain
- Interventions
- Other: Adenosine-stress cardiac magnetic resonance imaging
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 104
- Registration Number
- NCT02575768
Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
Not Applicable
Completed
- Conditions
- Proton TherapyLiver NeoplasmPortal Vein Tumor Thrombosis
- Interventions
- Radiation: Proton beam therapy
- First Posted Date
- 2015-10-08
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 53
- Registration Number
- NCT02571946
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
Phase 2
- Conditions
- Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
- Interventions
- First Posted Date
- 2015-09-24
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02558387
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Prospective Registration of Head and Neck Cancer
Recruiting
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 2000
- Registration Number
- NCT02546895
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)
Phase 2
- Conditions
- Extranodal NK-T-Cell Lymphoma
- Interventions
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 27
- Registration Number
- NCT02544425
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT02544997
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma
- First Posted Date
- 2015-08-28
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT02535650
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease
Phase 3
- Conditions
- Laryngopharyngeal Reflux Disease
- Interventions
- First Posted Date
- 2015-08-26
- Last Posted Date
- 2016-06-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT02533349
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A New Track Ablation Device for Liver Biopsy: A Feasibility Study
Phase 1
- Conditions
- Liver Neoplasms
- Interventions
- Device: Biopsy Track Ablator (STARmed, Goyang, Korea)
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2015-08-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02521129
© Copyright 2025. All Rights Reserved by MedPath